(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
|
It was reported that during a procedure of the mildly calcified, mid right coronary artery (rca), after placement of the balance middleweight guide wire in the anatomy, the 3.25 x 20 mm nc trek balloon dilatation catheter (bdc) met resistance advancing and during removal over the guide wire.The nc trek bdc was removed from the anatomy separately from the guide wire.It was noted that two other non-abbott bdcs were advanced over the guide wire without resistance prior to the nc trek being used.The procedure was completed using the same guide wire and a non-abbott stent being deployed.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
|
(b)(4).Evaluation summary: visual, dimensional and functional testing were performed on the returned device.The reported difficulties were confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other incidents from this lot.It should be noted the cdc (coronary dilatation catheter), nc trek rx, global instructions for use states: note: submerge the balloon in sterile heparinized normal saline during balloon preparation, to activate the coating.The investigation was unable to determine a conclusive cause for the reported difficulties.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|